Silexion Therapeutics Corp (NASDAQ:SLXN) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Ruth Alon Other companies: Alpha Tau Medical Ltd (Director · Since at least Mar 18, 2026); Vascular Biogenics Ltd (Director · Jan 1, 2023 – Jan 1, 2023 · Past); Moringa Acquisition Corp (Director · Feb 16, 2021 – Feb 16, 2021 · Past); Chemomab Therapeutics Ltd. (Director · Jan 1, 2020 – Jan 1, 2020 · Past) | Director · Since at least Aug 15, 2024 |
| Avner Lushi Other companies: BrainsWay Ltd (Director · Since at least Mar 18, 2026) | Director · Since at least Aug 15, 2024 |
| Ilan Levin Other companies: Moringa Acquisition Corp (Chairman and CEO, Director · Feb 16, 2021 – Feb 16, 2021 · Past) | Director · Since at least Aug 15, 2024 |
| Amnon Peled | Director · Since at least Dec 10, 2024 |
| Dror Abramov | Director · Since at least Aug 15, 2024 |
| Hadar Mirit Horenshtein | CFO and Secretary · Since at least Aug 15, 2024 |
| Ilan Hadar | Chairman · Since at least Aug 15, 2024 |
| Ilan Shiloah | Director · Aug 15, 2024 – Aug 15, 2024 · Past |
| Michal Yaron | VP RA · Since at least Nov 4, 2026 |
| Mirit Horenshtein Hadar | Chief Financial Officer · Since at least Sep 9, 2026 |
| Mitchell Shirvan | Chief Scientific and Development Officer · Since at least Aug 15, 2024 |
| Orit Pollack Shragai | VP Clinical Operations · Since at least Nov 4, 2026 |
| Racheli Gabai-Malka | VP Pharmaceutical Development · Since at least Nov 4, 2026 |
| Shlomo Noy | Director · Since at least Aug 15, 2024 |
| Silexion Therapeutics CorpMs. Mirit Horenshtein Hadar | Capital Markets Advisors for Silexion · Jan 15, 2025 – Nov 4, 2026 · Past |